Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells (2021)
- Authors:
- Machado, Rafael Rahal Guaragna
- Glaser, Talita
- Araujo, Danielle Bastos
- Petiz, Lyvia Lintzmaier
- Durigon, Danielle Bruna Leal de Oliveira
- Durigon, Giuliana Stravinskas
- Leal, Alessandra L.
- Pinho, Joao Renato Rebello
- Ferreira, Luís Carlos de Souza
- Ulrich, Henning
- Durigon, Edison Luiz
- Carvalho, Cristiane Rodrigues Guzzo
- Machado, Rafael Rahal Guaragna
- USP affiliated authors: DURIGON, DANIELLE BRUNA LEAL DE OLIVEIRA - ICB ; PINHO, JOÃO RENATO REBELLO - FM ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; ULRICH, ALEXANDER HENNING - IQ ; DURIGON, EDISON LUIZ - ICB ; CARVALHO, CRISTIANE RODRIGUES GUZZO - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; GLASER, TALITA - IQ ; PETIZ, LYVIA LINTZMAIER - IQ
- Unidades: ICB; FM; IQ
- DOI: 10.1021/acsptsci.1c00080
- Subjects: COVID-19; REPLICAÇÃO VIRAL; SAIS; MICROBIOLOGIA; CÉLULAS EPITELIAIS; CORONAVIRUS; SÍNDROME CORONARIANA AGUDA; DOENÇAS RESPIRATÓRIAS; MEMBRANA PLASMÁTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2021
- Source:
- Título do periódico: ACS Pharmacolology and Translational Science
- ISSN: 2575-9108
- Volume/Número/Paginação/Ano: v. 4, n. 5, p. 1514–1527, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: unspecified-oa
-
ABNT
MACHADO, Rafael Rahal Guaragna et al. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, v. 4, n. 5, p. 1514–1527, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsptsci.1c00080. Acesso em: 23 maio 2024. -
APA
Machado, R. R. G., Glaser, T., Araujo, D. B., Petiz, L. L., Durigon, D. B. L. de O., Durigon, G. S., et al. (2021). Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells. ACS Pharmacolology and Translational Science, 4( 5), 1514–1527. doi:10.1021/acsptsci.1c00080 -
NLM
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 maio 23 ] Available from: https://doi.org/10.1021/acsptsci.1c00080 -
Vancouver
Machado RRG, Glaser T, Araujo DB, Petiz LL, Durigon DBL de O, Durigon GS, Leal AL, Pinho JRR, Ferreira LC de S, Ulrich H, Durigon EL, Carvalho CRG. Inhibition of severe acute respiratory syndrome coronavirus 2 replication by hypertonic saline solution in lung and kidney epithelial cells [Internet]. ACS Pharmacolology and Translational Science. 2021 ; 4( 5): 1514–1527.[citado 2024 maio 23 ] Available from: https://doi.org/10.1021/acsptsci.1c00080 - Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
- P2Y14 receptor as a target for neutrophilia attenuation in severe COVID -19 cases: from hematopoietic stem cell recruitment and chemotaxis to thrombo-inflammation
- Neonatal consequences of maternal exposure to the chikungunya virus
- Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Distinct immunological profiles help in the maintenance of salivary secretory IgA production in mild symptoms COVID-19 patients
- Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4/5 bivalent Booster
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
Informações sobre o DOI: 10.1021/acsptsci.1c00080 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
